LabPulse.com staff writersEmerging TechnologyWeek in Review: Rising genomics wave | Rapid stroke diagnosis | Lab leader surveyFebruary 8, 2025Research GrantAstraDx receives $30M CARB-X funding for neonatal sepsis testCombating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has awarded $3 million to diagnostics company AstraDx to develop a rapid test for neonatal sepsis.February 7, 2025SequencingHelix launches genomic dataset of GLP-1 agonist-treated patientsGenetic testing and population genomics firm Helix announced the launch of a research-ready clinico-genomic dataset of over 15,000 patients treated with glucagon-like-peptide-1 (GLP-1) agonists.February 7, 2025Mergers & AcquisitionsBD to separate biosciences and diagnostics business from companyBecton Dickinson (BD) announced that its board of directors has unanimously authorized a plan to separate its biosciences and diagnostic solutions business from the rest of the company.February 6, 2025Molecular DiagnosticsABL, Siemens Healthineers sign licensing agreementAdvanced Biological Laboratories (ABL) and Siemens Healthineers have signed a licensing and transfer agreement of know-how and intellectual property rights from Fast Track Diagnostics Luxembourg to ABL.February 6, 2025Regulatory ApprovalAliveDx gets CE Mark for multiplex autoimmune testAliveDx has received the CE Mark for its multiplex assay for the diagnosis of systemic autoimmune rheumatic diseases.February 5, 2025Diagnostic TechnologiesStudy findings presented on early stroke-type detection testA new blood test may rapidly distinguish stroke type before people with stroke symptoms reach the emergency department, according to a preliminary study being presented at the American Stroke Association's International Stroke Conference 2025.February 5, 2025Diagnostic TechnologiesU.K. lab leader survey brings 3 key issues to frontStudy shows goals for staff retention, upskilling lab teams, and narrowing STEM gap.February 5, 2025FDA ClearanceVertex non-opioid analgesic gets FDA approvalThe U.S. Food and Drug Administration (FDA) has approved Vertex’s Journavx, the first analgesic to be approved in a novel class of non-opioid pain medications indicated for moderate to severe acute pain relief.February 4, 2025LawsuitPTAB rules 10x Genomics patent claims invalid in Parse suitThe Patent Trial and Appeal Board (PTAB) has invalidated all claims of patent infringement in 10x Genomics' lawsuit against Parse Biosciences.February 4, 2025Page 1 of 377Next PageTop StoriesLawsuitLegal team highlights cautionary clinical laboratory fraud caseClinical laboratory litigation indicates growing trend of cases filed by nontraditional whistleblowers.Emerging TechnologyWhat's coming in clinical genomics?Policy and RegulationLab leaders advised to maintain communication with regulatory agencies during blackoutLawsuitFederal judge dismisses pathology group antitrust caseSponsor ContentBody composition in patients treated with Ozempic